• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO Group Keeps Lid On Bird Flu Lab Results – For Now

17/02/2012 by Intellectual Property Watch 1 Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

A group of public health experts gathered by the World Health Organization agreed today to continue a temporary moratorium on research done on the H5N1 bird flu virus modified in a laboratory to be more transmissible between mammals. But they said research should continue on the naturally occurring version of the virus.

The closed door meeting took place at WHO on 16-17 February.

Concern arose recently when it became known that research groups in the Netherlands and the United States have “created versions of the H5N1 influenza virus which are more transmissible in mammals than the H5N1 virus that occurs naturally,” as WHO put it, leading the health agency to convene the group.

The group consisted of various interested parties – including the researchers, the funders of the research, publications that want to profit from publishing the research, the countries that provided the viruses, bioethicists, and directors from several WHO “collaborating-center laboratories specializing in influenza,” WHO said. Publication of the manuscripts of the research will be delayed.

More meetings will be held in the future. It is expected that they will agree to publish the research later this year, according to sources.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"WHO Group Keeps Lid On Bird Flu Lab Results – For Now" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

Comments

  1. Riaz K Tayob says

    18/02/2012 at 7:01 pm

    This is just power politics. Even the contributions of viruses that developing countries routinely make to WHO are captured in databases on the evolution of the virus in certain labs approved by WHO. Access to these databases is proprietary, whereas they are derived from “free” donations of protected biodiversity of developing countries. How can regional capacity be developed for vaccines when this kind of imbalance is apparent in the world system (that a tracking system of donations does not even deal with)?

    When WHO was caught with its pants down allowing companies to expropriate developing country knowledge from viruses in contravention of its own guidelines, it simply removed them from its website. This is the balance and fairness from impartial civil servants…

    And if a developing country health minister makes a conspiratorial point, that biological weapons are possibility (she may have been over the top, but not far off the mark as things go) polite sensible opinion dismissed her as a freak.

    One wonders at the advice WHO receives when IPR matters were pulled to the highest levels of the WHO governance structure… when will poor people matter for WHO that tips its hat defering to the WTO and WIPO as a UN agency but at least on Human Rights Rapporteurs show now such feudal deference…

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.